Compounds > alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc

alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Arteriosclerosis

alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc has been researched along with Arteriosclerosis* in 1 studies

Reviews

1 review(s) available for alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Arteriosclerosis

ArticleYear
Anti-adhesion therapy.
    Advances in pharmacology (San Diego, Calif.), 1997, Volume: 39

    Topics: Antibodies, Monoclonal; Arteriosclerosis; Arthritis; Burns; Humans; Immunoglobulins; Inflammation; Integrins; Intercellular Adhesion Molecule-1; Leukocytes; Oligosaccharides; Reperfusion Injury; Selectins; Sialyl Lewis X Antigen

1997